Anagliptin is a selective dipeptidyl peptidase-4 (DPP-4) inhibitor used in the management of type 2 diabetes, where it functions by increasing insulin secretion and suppressing glucagon release. This category… Read more
Anagliptin is a selective dipeptidyl peptidase-4 (DPP-4) inhibitor used in the management of type 2 diabetes, where it functions by increasing insulin secretion and suppressing glucagon release. This category features a selection of high-quality reference materials essential for comprehensive analytical testing and quality control protocols in pharmaceutical research. These materials include the parent drug compound alongside critical impurities and stable isotope labelled standards required for impurity profiling and method validation. Laboratories utilize the stable isotope labelled versions, such as anagliptin-d6, as internal standards in quantitative mass spectrometry to ensure precise results. Additionally, researchers rely on specific degradation products and synthesis-related impurities—including nitrosamines—to develop robust detection methods and monitor product stability throughout the development lifecycle. Having access to these characterized substances is vital for maintaining regulatory compliance and ensuring the safety and efficacy of therapeutic formulations.